fda semaglutide obesity approves drug that helped people cut weight 15% US FDA approves weight loss

Whether medical insurance will in the future cover costs when GLP-1s can be prescribed for smoking cessation or cardiovascular health remains to be seen

The primary mechanisms through which Wegovy exerts its effects include slowing gastric emptying, which prolongs the sensation of fullness after meals, and acting on appetite centres in the hypothalamus to reduce hunger signals

The Treatment Imperative: Effectively managing obesity is now recognized as a primary strategy to curb the rise of T2D and its life-threatening complications

A major shift is underway in India's obesity and diabetes care, as semaglutide's patent expiry is set to make weight-loss injections far more affordable